A Phase 1
Sponsors
Syndax Pharmaceuticals, Inc., Medicines Company
Conditions
Acinetobacter infections
Not applicableAdvanced cancer
Unknown Phase
A PHASE 1, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL IN HEALTHY VOLUNTEERS TO DETERMINE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ESCALATING SINGLE AND MULTIPLE DOSES OF SNDX-6352 OR PLACEBO ADMINISTERED BY INTRAVENOUS (I.V.) INFUSION
Active, not recruitingNL-OMON42865
Start: 2016-10-20Target: 52Updated: 2024-02-28
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics of Minocin® (minocycline) for Injection in Healthy Adult Subjects
Active, not recruitingNL-OMON45336
Start: 2017-04-11Target: 60Updated: 2024-02-28